Dec 2023 | Mar 2022 | ||
---|---|---|---|
Total Revenue | |||
Cost of Revenue | |||
Gross Profit | |||
Gross Profit Margin (%) | |||
R&D Expense | |||
SG&A Expense | |||
Total Operating Expenses | |||
Operating Income or Loss | |||
Operating Margin (%) | |||
Interest Expense | |||
Total Other Income/Expenses | |||
Income Before Tax | |||
Income Tax Expense | |||
Income from Continuing Ops. | |||
Net Income | |||
Net Profit Margin (%) | |||
Net Income Available to Common Shareholders | |||
Basic EPS | |||
Diluted EPS | |||
Basic Average Shares | |||
Diluted Average Shares |
Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Sep 2022 | Jun 2022 | Mar 2022 | ||
---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||
Cost of Revenue | ||||||||||
Gross Profit | ||||||||||
Gross Profit Margin (%) | ||||||||||
R&D Expense | ||||||||||
SG&A Expense | ||||||||||
Total Operating Expenses | ||||||||||
Operating Income or Loss | ||||||||||
Operating Margin (%) | ||||||||||
Interest Expense | ||||||||||
Total Other Income/Expenses | ||||||||||
Income Before Tax | ||||||||||
Income Tax Expense | ||||||||||
Income from Continuing Ops. | ||||||||||
Net Income | ||||||||||
Net Profit Margin (%) | ||||||||||
Net Income Available to Common Shareholders | ||||||||||
Basic EPS | ||||||||||
Diluted EPS | ||||||||||
Basic Average Shares | ||||||||||
Diluted Average Shares |
Dec 2023 | Mar 2022 | ||
---|---|---|---|
Current Assets | |||
Cash & Cash Equivalents | |||
Marketable Securities | |||
Receivables | |||
Inventories | |||
Other Current Assets | |||
Total Current Assets | |||
Non-Current Assets | |||
Marketable Securities | |||
PPE Net | |||
Intangibles inc. Goodwill | |||
Other Non-Current Assets | |||
Total Non-Current Assets | |||
Total Assets | |||
Current Liabilities | |||
Accounts Payable | |||
Deferred Revenues | |||
Debt, Current | |||
Accrued Liabilities | |||
Other Current Liabilities | |||
Total Current Liabilities | |||
Non-Current Liabilities | |||
Deferred Revenues | |||
Debt, Non-Current | |||
Other Non-Current Liabilities | |||
Total Non-Current Liabilities | |||
Total Liabilities | |||
Shareholders' Equity | |||
Common Stock | |||
Additional Paid-In Capital | |||
Retained Earnings | |||
Other Shareholders' Equity | |||
Total Shareholders' Equity | |||
Total Liabilities & Shareholders' Equity |
Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Sep 2022 | Jun 2022 | Mar 2022 | ||
---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||
Cash & Cash Equivalents | ||||||||||
Marketable Securities | ||||||||||
Receivables | ||||||||||
Inventories | ||||||||||
Other Current Assets | ||||||||||
Total Current Assets | ||||||||||
Non-Current Assets | ||||||||||
Marketable Securities | ||||||||||
PPE Net | ||||||||||
Intangibles inc. Goodwill | ||||||||||
Other Non-Current Assets | ||||||||||
Total Non-Current Assets | ||||||||||
Total Assets | ||||||||||
Current Liabilities | ||||||||||
Accounts Payable | ||||||||||
Deferred Revenues | ||||||||||
Debt, Current | ||||||||||
Accrued Liabilities | ||||||||||
Other Current Liabilities | ||||||||||
Total Current Liabilities | ||||||||||
Non-Current Liabilities | ||||||||||
Deferred Revenues | ||||||||||
Debt, Non-Current | ||||||||||
Other Non-Current Liabilities | ||||||||||
Total Non-Current Liabilities | ||||||||||
Total Liabilities | ||||||||||
Shareholders' Equity | ||||||||||
Common Stock | ||||||||||
Additional Paid-In Capital | ||||||||||
Retained Earnings | ||||||||||
Other Shareholders' Equity | ||||||||||
Total Shareholders' Equity | ||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2023 | Mar 2022 | ||
---|---|---|---|
Cash Flows from Operating Activities | |||
Net Income | |||
Depreciation & Amortization | |||
Deferred Income Taxes | |||
Stock Based Compensation | |||
Accounts Receivable | |||
Inventory | |||
Accounts Payable | |||
Deferred Revenue | |||
Other Non-Cash | |||
Operating Cash Flow | |||
Cash Flows from Investing Activities | |||
PPE Investments | |||
Net Acquisitions | |||
Purchase of Investments | |||
Sale of Investments | |||
Other Investing Activity | |||
Investing Cash Flow | |||
Cash Flows from Financing Activities | |||
Debt Issued | |||
Proceeds from Debt Repayment | |||
Debt Repayment | |||
Proceeds from Sale of Equity | |||
Equity Repurchased | |||
Dividend Paid | |||
Other Financing Activity | |||
Financing Cash Flow | |||
Cash Position | |||
Beginning Cash Position | |||
End Cash Position | |||
Change in Cash | |||
Free Cash Flow | |||
Operating Cash Flow | |||
Capital Expenditure | |||
Free Cash Flow |
Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Sep 2022 | Jun 2022 | Mar 2022 | ||
---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||
Net Income | ||||||||||
Depreciation & Amortization | ||||||||||
Deferred Income Taxes | ||||||||||
Stock Based Compensation | ||||||||||
Accounts Receivable | ||||||||||
Inventory | ||||||||||
Accounts Payable | ||||||||||
Deferred Revenue | ||||||||||
Other Non-Cash | ||||||||||
Operating Cash Flow | ||||||||||
Cash Flows from Investing Activities | ||||||||||
PPE Investments | ||||||||||
Net Acquisitions | ||||||||||
Purchase of Investments | ||||||||||
Sale of Investments | ||||||||||
Other Investing Activity | ||||||||||
Investing Cash Flow | ||||||||||
Cash Flows from Financing Activities | ||||||||||
Debt Issued | ||||||||||
Proceeds from Debt Repayment | ||||||||||
Debt Repayment | ||||||||||
Proceeds from Sale of Equity | ||||||||||
Equity Repurchased | ||||||||||
Dividend Paid | ||||||||||
Other Financing Activity | ||||||||||
Financing Cash Flow | ||||||||||
Cash Position | ||||||||||
Beginning Cash Position | ||||||||||
End Cash Position | ||||||||||
Change in Cash | ||||||||||
Free Cash Flow | ||||||||||
Operating Cash Flow | ||||||||||
Capital Expenditure | ||||||||||
Free Cash Flow |